CRISPR 和 CAS 基因市场规模、份额、成长分析、按产品、按服务、按应用、按最终用户、按地区 - 行业预测，2025-2032 年

2023年CRISPR和CAS基因市场规模为35亿美元，从2024年的47.8亿美元成长到2032年的583.3亿美元，复合年增长率预计将成长36.70%。

近年来，在不同领域对基因编辑工具和治疗方法的需求不断增长的推动下，CRISPR 和 CAS 基因市场经历了显着的成长和演变。我们的综合报告包括广泛的价值链分析，以帮助製造商在这个不断扩大的市场中获得竞争优势。主要驱动力包括扩大医疗保健、农业和工业生物技术应用范围的技术进步。 CRISPR（成簇规则间隔短回文重复）和 Cas（CRISPR 相关）技术正在彻底改变基因工程并提高 DNA 修饰的精确度。儘管存在伦理和监管方面的挑战，但遗传疾病的扩散、正在进行的研究和研究合作正在进一步加速成长。随着技术的进步和我们对基因功能的了解加深，CRISPR 和 CAS 市场有望改变多个行业。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管环境
• 案例研究
• 技术进步

CRISPR 和 CAS 基因市场规模：依产品

• 市场概况
• 试剂套件和试剂
  • Cas蛋白和酶
  • 引导RNA
  • 其他的
• 图书馆
• 设计工具
• 抗体
• 其他的

CRISPR 和 CAS 基因市场规模：按服务分类

• 市场概况
• 细胞株工程
• GRNA设计与合成
• 筛检服务
• 其他的

CRISPR 和 CAS 基因市场规模：按应用分类

• 市场概况
• 生物医学
  • 基因组工程
  • 疾病模型研究
  • 功能基因体学
  • 表观遗传学
  • 其他的
• 农业

CRISPR 和 CAS 基因市场规模：按最终用户分类

• 市场概况
• 生物技术和製药公司
• 学术和政府研究机构
• 合约研究组织（CROS）
• 其他的

CRISPR和CAS基因市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• CRISPR Therapeutics（Switzerland）
• Beam Therapeutics（USA）
• Intellia Therapeutics（USA）
• Editas Medicine（USA）
• Caribou Biosciences（USA）
• Verve Therapeutics（USA）
• Prime Medicine（USA）
• Sangamo Therapeutics（USA）
• Wave Life Sciences（Singapore）
• Metagenomi（USA）
• Mammoth Biosciences（USA）
• Synthego Corporation（USA）
• EGenesis（USA）
• Inscripta（USA）
• Cellectis（France）
• OriGene Technologies（USA）
• Precision BioSciences（USA）
• Recombinetics（USA）

结论和建议

CRISPR and CAS Gene Market size was valued at USD 3.5 Billion in 2023 and is poised to grow from USD 4.78 Billion in 2024 to USD 58.33 Billion by 2032, growing at a CAGR of 36.70% during the forecast period (2025-2032).

The CRISPR and CAS gene market has undergone remarkable growth and evolution recently, fueled by rising demand for gene-editing tools and therapies across diverse sectors. Our comprehensive report includes an extensive value chain analysis, empowering manufacturers to secure a competitive advantage in this expanding market. Key drivers include technological advancements that broaden application scopes in healthcare, agriculture, and industrial biotechnology. The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and Cas (CRISPR-associated) technologies have revolutionized genetic engineering, offering precision in DNA modification. The surge in genetic disorders, ongoing research, and collaboration further accelerate growth, despite ethical and regulatory challenges. As technology progresses and understanding of gene functions deepens, the CRISPR and CAS market is set to transform multiple industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the CRISPR and CAS Gene market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

CRISPR and CAS Gene Market Segmental Analysis

Global CRISPR and CAS Gene Market is segmented by product, service, application, end user and region. Based on product, the market is segmented into kits & reagents, libraries, design tool, antibodies and others. Based on service, the market is segmented into cell line engineering, GRNA design & synthesis, screening services and others. Based on application, the market is segmented into biomedical and agricultural. Based on end user, the market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes, contract research organizations (CROS) and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the CRISPR and CAS Gene Market

The CRISPR and CAS Gene market is significantly driven by the rising prevalence of genetic disorders, which include various conditions stemming from mutations or changes in specific genes. As the understanding of these genetic conditions deepens, there is a growing demand for advanced and precise gene-editing technologies like Crispr and Cas. These innovative tools offer tremendous potential for creating targeted therapies and personalized treatment approaches for patients with genetic disorders. The increasing global incidence of genetic diseases, combined with the urgent need for effective treatment solutions, fuels the demand for Crispr and Cas technologies, thus accelerating market expansion.

Restraints in the CRISPR and CAS Gene Market

The CRISPR and CAS Gene market faces several restraints primarily stemming from regulatory and ethical challenges associated with gene editing technologies. While the transformative power of Crispr offers immense possibilities, it simultaneously raises significant concerns regarding its responsible and ethical application. Discussions around the implications of germline editing, potential off-target effects, and unforeseen consequences fuel ongoing debates within the scientific community and beyond. Moreover, the lack of uniform regulatory frameworks across various countries and regions creates inconsistencies that may hinder market growth and restrict the adoption of these innovative gene-editing solutions, thereby impacting their overall potential in various applications.

Market Trends of the CRISPR and CAS Gene Market

The CRISPR and Cas gene market is witnessing significant growth, particularly in the agricultural sector, driven by the increasing adoption of gene editing technologies to enhance crop traits and resilience. Farmers and breeders are leveraging CRISPR for precise modifications, enabling the development of genetically modified organisms (GMOs) that exhibit superior yield, disease resistance, and adaptive traits like drought tolerance. This trend is heavily influenced by the urgent need for sustainable agricultural practices, heightened by global food security challenges and a rising population. As stakeholders seek innovative solutions, the CRISPR market is poised for expansion, fostering advancements in crop productivity and sustainable farming practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global CRISPR and CAS Gene Market Size by Product & CAGR (2025-2032)

• Market Overview
• Kits & Reagents
  • Cas Proteins & Enzymes
  • Guide RNA
  • Others
• Libraries
• Design Tool
• Antibodies
• Others

Global CRISPR and CAS Gene Market Size by Service & CAGR (2025-2032)

• Market Overview
• Cell Line Engineering
• GRNA Design & Synthesis
• Screening Services
• Others

Global CRISPR and CAS Gene Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biomedical
  • Genome Engineering
  • Disease Model Studies
  • Functional Genomics
  • Epigenetics
  • Others
• Agricultural

Global CRISPR and CAS Gene Market Size by End User & CAGR (2025-2032)

• Market Overview
• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Contract Research Organizations (CROS)
• Others

Global CRISPR and CAS Gene Market Size & CAGR (2025-2032)

• North America (Product, Service, Application, End User)
  • US
  • Canada
• Europe (Product, Service, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Service, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Service, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Service, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CRISPR Therapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caribou Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verve Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prime Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wave Life Sciences (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metagenomi (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EGenesis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inscripta (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision BioSciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recombinetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations